secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K/A
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001477932-23-007962
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab amends 8-K to disclose CEO and CFO are father and daughter
----------------------------------------------------------------------------

- CEO Chi Yuen Leong's daughter, Wei Li Leong, serves as CFO.
- Disclosure corrects omission in original October 2023 8-K.
- No other changes to the original report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793223007962/0001477932-23-007962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793223007962/bglc_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-007962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer